$LLLI Lamperd Less Lethal Approved for Financial Package to

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
143
$ LLLI Lamperd Less Lethal Approved for Financial Package to Support Product Development Research Program with Lambton College

SARNIA, Ontario, September 11, 2019 Lamperd Less Lethal, Inc. (OTC PINK: LLLI), an innovation leader and manufacturer of advanced security solutions for law enforcement, military and security agencies worldwide, is pleased to announced that the company has been approved for a financial support package from the SONAMI program of the Canadian government to conduct a research program in conjunction with Lambton College of Ontario. The purpose of this research is to test new methods for the concentration of Lamperd's pepper formula used in its aerial burst and hand thrown devices for crowd control. No other company in the world parallels the extent to which Lamped develops these types of products for safety and effectiveness. This research program will commence on September 23, 2019 and run for a period of six months.

Project Title:

Development of Standardized Procedure of Capsaicin Quantification in Aerosolized Crowd Control Devices

Synopsis:

Non-lethal methods of crowd and personnel control is a growing market as lethal methods become less acceptable. Pepper spray is a key tool in the non-lethal arsenal. Currently, there are guidelines for the potency of pepper sprays, but no rules or laws and most importantly, no methods are in place to actually measure personnel exposure in the deployment of these sprays. As more and more scrutiny of any use of force becomes the norm, scientific, quantized levels of pepper spray exposure is highly likely to be required. The proposed work would create a method of collecting aerosolized samples during the use of pepper spray devices within the pepper cloud. Further, a method of measuring that sample will also be developed and both may be presented to the industry for adoption as a standard at the discretion of the industry partner.

Benefit to Private Sector:

The opportunity lies in competitive advantage by providing weaponized pepper products with measured and certified levels of capsaicin and related capsaicinoids (CRC), as well as getting ahead of eventual regulatory requirements. The military market is beginning to understand that lethal force is not always desirable and is asking for certification to ensure consistent levels of CRC are delivered and that batches are tracked. The police market is increasingly being drawn into litigation for real or imagined physical and emotional damages when lethal or non-lethal force is applied. The ability to quantify and certify the CRC level of nonlethal weapons used will provide them with a powerful tool in fighting these legal battles and will soon be required.

The non-lethal ammunition market is expected to grow to $5.2 billion per year by 2025, with a compound annual growth rate of 8.3% over that period. Lamperd Less Lethal is a key player in this industry and is anticipating even more rapid growth.

About the Company

Lamperd Less Lethal, Inc. (LLLI) is a developer, manufacturer and international sales company for advanced less lethal weapons, ammunition and other security products marketed to police, correctional, military and private security forces. The company sells over 300 different products including small & large caliber projectile guns, flash-bang devices, pepper spray devices, 37mm & 40mm launching systems and interlocking riot shields. Lamperd also offers advisory services and hands-on training classes run by highly accredited instructors. For more information visit: http://www.lamperdlesslethal.com.

This press release contains forward-looking statements relating to Lamperd Less Lethal, Inc. Lamperd Less Lethal, Inc. undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes in future operating results.

Safe Harbor for Forward-Looking Statements:

This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact: Lamperd Less Lethal, Inc.

Barry Lamperd, President & CEO

(519) 344-4445


email: info@lamperdlesslethal.com or sales@lamperdlesslethal.com

Company Website: http://www.lamperdlesslethal.com

Lamperd Less Lethal on Facebook: http://www.facebook.com/lamperdlesslethal

Lamperd Less Lethal on Instagram: http://www.instagram.com/llli_lamperd_lesslethal

Barry Lamperd on Twitter: http://www.twitter.com/lamperd_llli
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG OLED evo W6: UAE Roadshow Starts with a Bang

Updated Category News Views 20

They've done it again, folks. LG Electronics is out there kicking up a storm with their all-new OLED evo W6 True Wireless Wallpaper TV, and they're bringing the action straight to the UAE's doorsteps. Imagine taking a stroll and stumbling upon this technological marvel at some fancy spot like The Lotus Lounge at Anantara The Palm Dubai Resort. This ain't just a TV, it's a...

Continue Reading
Weifang's Cultural Resurgence: A Global Epigraphy Fest

Updated Category News Views 13

A Historical Meltdown into Global Recognition Welcome to the ride where ancient stones talk and cultural borders vanish. We're diving into the beating heart of Weifang, a place you're probably hearing about now because the town's hosting a packed international media tour. And, for a change, this isn't just another tourist trap; it's a cultural adrenaline shot to the arm,...

Continue Reading
Innventure Faces Major Lawsuit Over Misleading Investors

Updated Category News Views 15

Missteps at Innventure: A Costly Lesson in Investor Trust The stock market is no stranger to drama, but Innventure's saga feels like a page ripped right out of a thriller novel. You’ve got accusations, alleged fabrications, and a swift drop in stock prices that’s left some investors shaking their heads. The company, nestled under the ticker NASDAQ:INV, finds itself...

Continue Reading
Masimo's smartSET™ Revolutionizes Patient Monitoring

Updated Category News Views 14

Breaking Ground in Patient Monitoring Let's dive into the gritty details behind Masimo's latest FDA-nod: the smartSET™ system. This gizmo ain't your ordinary pulse oximeter; it's a next-gen hand-holder for the medical world, poised to ride the AI wave straight into the clinic. They've cracked open a new way for clinicians to peek behind the curtain of patient vitals,...

Continue Reading
AEVEX Facing Class Action Deadline Amid Stock Turmoil

Updated Category News Views 14

Investors are no strangers to the rough and tumble of stock markets, but things get downright messy when trust is shattered. That's the sorry saga unfolding with AEVEX, where shareholders are feeling the heat after a sharp nosedive in stock value. The clock is ticking to join the class action, and any AEVEX investor worth their salt should pay attention. Unraveling...

Continue Reading
Voter Events by Valley Community Healthcare Aim to Empower

Updated Category News Views 14

Here's a game-changer for the community. Valley Community Healthcare (VCH) is stepping up, proving that healthcare doesn't just stick to check-ups and prescriptions. It's about the whole shebang—community empowerment included. This October, VCH is hosting two incredible voter events, collaborating with the Los Angeles County Registrar-Recorder's Mobile Voting Program....

Continue Reading
Hyliion Class Action Deadline Nears for Investors

Updated Category News Views 14

Potential Shockwaves for Hyliion Investors Investors are having a showdown with Hyliion (NYSE:HYLN) these days. With the looming October 27, 2026, deadline to jump into a securities class action, it seems Hyliion's latest escapade smells worse than a fish market on a hot day. We’ve got allegations here stronger than your uncle’s morning coffee. Understanding the Legal...

Continue Reading

Top 5 Most Recently Viewed Articles

FDA's NMN Ruling: Naturecan Seizes Opportunities for Growth

Updated Category News Views 158

FDA's NMN Ruling and Its Significance Naturecan, a prominent global wellness brand, is thrilled by the recent ruling from the U.S. Food and Drug Administration (FDA) regarding ?-Nicotinamide Mononucleotide (NMN). This ruling confirms that NMN is lawful for use in dietary supplements in the United States, paving the way for significant advancements within the global...

Continue Reading
Casepoint Secures Major SEC Contract for Innovative Data Solutions

Updated Category News Views 184

Casepoint Secures Important Contract Extension with the SEC Casepoint, a leading company in data discovery technology, has successfully extended its contract with the U.S. Securities and Exchange Commission (SEC). This five-year agreement highlights Casepoint's dedication to providing secure, cloud-based solutions designed for regulatory enforcement and compliance in a...

Continue Reading
Intel Corp's Future with Apple: Chip Manufacturing Wins

Updated Category News Views 359

Intel Corp's Significant Stock Surge Intel Corp (NASDAQ: INTC) saw its stock rise by 7%, thanks to a report signaling the company's exciting potential to produce chips for Apple Inc's upcoming Mac models. Industry analyst Ming-Chi Kuo from TF International Securities provided an optimistic outlook, suggesting Intel is gaining traction in its efforts to expand operations....

Continue Reading
Significant Phase II Breakthrough for Akeso's Ivonescimab in NSCLC

Updated Category News Views 195

Akeso's Promising Results with Ivonescimab for Lung Cancer Akeso (9926.HK) has recently shared exciting findings from the Phase II study of ivonescimab, a groundbreaking PD-1/VEGF bispecific antibody designed to treat resectable non-small cell lung cancer (NSCLC). This study was highlighted during a key oral session at the 25th World Conference on Lung Cancer (WCLC),...

Continue Reading
Insider Trades at Sherwin-Williams: A Closer Look at Rea's Moves

Updated Category News Views 204

Recent Insider Trading Activity at Sherwin-Williams Todd Rea, who holds the position of President at Sherwin-Williams (NYSE: SHW), has recently become the center of attention due to his stock option activities. The latest SEC filing reveals that he made a notable decision by exercising options for zero shares of the company’s stock. What This Means for Investors In the...

Continue Reading